Login Register Cart 0
Generic placeholder image

Current Hypertension Reviews

Editor-in-Chief

ISSN (Print): 1573-4021
ISSN (Online): 1875-6506

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Cardiovascular Risk Related to Glomerular Hyperfiltration in Nondiabetic Individuals: Increasing Visibility is Crucial

Author(s): Rodolfo Valtuille*

Volume 19, Issue 3, 2023

Published on: 24 November, 2023

Page: [139 - 148] Pages: 10

DOI: 10.2174/0115734021268893231116045914

Price: $65

Abstract

Glomerular hyperfiltration (GHF), defined by different estimation formulas, has been widely studied as a predictor of proteinuria and progression to chronic kidney disease (CKD) in diabetic patients. GHF is also an important cardiovascular (CV) risk factor and is related to allcause mortality in non-diabetic populations; however, the upper limit of glomerular filtration rate (GFR) above which it indicates the presence of GHF is weakly defined. This higher risk is as high as in the intermediate stages of CKD and is greater than the presence of diabetes or smoking and is still present in non-albuminuria patients. The original Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) estimation GFR formula showed lower error at higher glomerular filtration (GF) values, was the most used in population studies, and behaved as a better risk predictor. In our review (including approximately 3.6 million individuals), higher GFR values related to increased mortality risk varied from 106.6 to 113.7 ml/min, which are usually not considered risk values for standard guidelines in non-albuminuric patients. However, the lack of consensus on a GF cutoff value, as well as its variability due to sex and progressive reduction with age, affect the knowledge of this serious phenomenon in clinical practice. Although the elderly population is not exempted from the effects of GHF, the search for this phenomenon should be intensified in middle-aged populations because of their lower disease burden, where this situation may be more evident, and the possibility of reversing the consequences is greater. A population group often considered healthy includes obese people, essential hypertensives, smokers, and carriers of fatty liver, where the GHF phenomenon is frequent and is associated with CV disease, kidney disease, and higher mortality. Increasing its visibility by the medical community is essential to reduce the effects of GHF, emphasizing more frequent controls and implementing general measures that include strict control of hypertension, Na restriction, rich in vegetables diets and increased physical activity. Initiatives to confirm the beneficial effects of sodium-glucose cotransporter-2 inhibitors to treat isolated GHF would be an important breakthrough in reducing the severe consequences of this phenomenon.

Next »
Graphical Abstract

[1]
Yoo KD, Yoon HJ, Hwang S, et al. Different association between renal hyperfiltration and mortality by sex. Nephrology 2017; 22(10): 804-10.
[http://dx.doi.org/10.1111/nep.12857] [PMID: 27436787]
[2]
Dupuis ME, Nadeau-Fredette AC, Madore F, Agharazii M, Goupil R. Association of glomerular hyperfiltration and cardiovascular risk in middle-aged healthy individuals. JAMA Netw Open 2020; 3(4): e202377.
[http://dx.doi.org/10.1001/jamanetworkopen.2020.2377] [PMID: 32275320]
[3]
Nitsch D, Grams M, Sang Y, et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: A meta-analysis. BMJ 2013; 346(jan29 1): f324.
[http://dx.doi.org/10.1136/bmj.f324] [PMID: 23360717]
[4]
Reboldi G, Verdecchia P, Fiorucci G, et al. Glomerular hyperfiltration is a predictor of adverse cardiovascular outcomes. Kidney Int 2018; 93(1): 195-203.
[http://dx.doi.org/10.1016/j.kint.2017.07.013] [PMID: 28935213]
[5]
Park M, Yoon E, Lim YH, Kim H, Choi J, Yoon HJ. Renal hyperfiltration as a novel marker of all-cause mortality. J Am Soc Nephrol 2015; 26(6): 1426-33.
[http://dx.doi.org/10.1681/ASN.2014010115] [PMID: 25343954]
[6]
Tonelli M, Klarenbach SW, Lloyd AM, et al. Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria. Kidney Int 2011; 80(12): 1306-14.
[http://dx.doi.org/10.1038/ki.2011.280] [PMID: 21849971]
[7]
Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: Prospective population based cohort study. BMJ 2010; 341(sep30 1): c4986.
[http://dx.doi.org/10.1136/bmj.c4986] [PMID: 20884698]
[8]
Cox HJ, Bhandari S, Rigby AS, Kilpatrick ES. Mortality at low and high estimated glomerular filtration rate values: A ‘U’ shaped curve. Nephron Clin Pract 2008; 110(2): c67-72.
[http://dx.doi.org/10.1159/000151720] [PMID: 18758185]
[9]
Putaala J, Haapaniemi E, Gordin D, et al. Factors associated with impaired kidney function and its impact on long-term outcome in young ischemic stroke. Stroke 2011; 42(9): 2459-64.
[http://dx.doi.org/10.1161/STROKEAHA.110.612721] [PMID: 21737795]
[10]
Inrig JK, Gillespie BS, Patel UD, et al. Risk for cardiovascular outcomes among subjects with atherosclerotic cardiovascular disease and greater-than-normal estimated glomerular filtration rate. Clin J Am Soc Nephrol 2007; 2(6): 1215-22.
[http://dx.doi.org/10.2215/CJN.00930207] [PMID: 17942781]
[11]
Kanbay M, Ertuglu LA, Afsar B, et al. Renal hyperfiltration defined by high estimated glomerular filtration rate: A risk factor for cardiovascular disease and mortality. Diabetes Obes Metab 2019; 21(11): 2368-83.
[http://dx.doi.org/10.1111/dom.13831] [PMID: 31297976]
[12]
Zoccali C, Mallamaci F. The overdriven glomerulus as a cardiovascular risk factor. Kidney Int 2018; 93(1): 13-5.
[http://dx.doi.org/10.1016/j.kint.2017.08.035] [PMID: 29291815]
[13]
Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311(2): 89-93.
[http://dx.doi.org/10.1056/NEJM198407123110204] [PMID: 6738599]
[14]
Epstein FH, Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982; 307(11): 652-9.
[http://dx.doi.org/10.1056/NEJM198209093071104] [PMID: 7050706]
[15]
Chakkera HA, Denic A, Kremers WK, et al. Comparison of high glomerular filtration rate thresholds for identifying hyperfiltration. Nephrol Dial Transplant 2020; 35(6): 1017-26.
[http://dx.doi.org/10.1093/ndt/gfy332] [PMID: 30403810]
[16]
Kalantar-Zadeh K, Fouque D. Nutritional management of chronic kidney disease. N Engl J Med 2018; 378(6): 583-5.
[http://dx.doi.org/10.1056/NEJMc1715765] [PMID: 29414270]
[17]
Cortinovis M, Perico N, Ruggenenti P, Remuzzi A, Remuzzi G. Glomerular hyperfiltration. Nat Rev Nephrol 2022; 18(7): 435-51.
[http://dx.doi.org/10.1038/s41581-022-00559-y] [PMID: 35365815]
[18]
Levey AS, Coresh J, Tighiouart H, Greene T, Inker LA. Measured and estimated glomerular filtration rate: Current status and future directions. Nat Rev Nephrol 2020; 16(1): 51-64.
[http://dx.doi.org/10.1038/s41581-019-0191-y] [PMID: 31527790]
[19]
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130(6): 461-70.
[http://dx.doi.org/10.7326/0003-4819-130-6-199903160-00002] [PMID: 10075613]
[20]
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150(9): 604-12.
[http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00006] [PMID: 19414839]
[21]
Young BA. Removal of race from estimation of kidney function. Nat Rev Nephrol 2022; 18(4): 201-2.
[http://dx.doi.org/10.1038/s41581-021-00524-1] [PMID: 35013595]
[22]
Pottel H, Björk J, Courbebaisse M, et al. Development and validation of a modified full age spectrum creatinine-based equation to estimate glomerular filtration rate. Ann Intern Med 2021; 174(2): 183-91.
[http://dx.doi.org/10.7326/M20-4366] [PMID: 33166224]
[23]
Congdon P, Amugsi D. Editorial: The obesity epidemic: Causes, context, prevention. Front Public Health 2022; 10: 1030180.
[http://dx.doi.org/10.3389/fpubh.2022.1030180] [PMID: 36225791]
[24]
Finkelstein EA, Khavjou OA, Thompson H, et al. Obesity and severe obesity forecasts through 2030. Am J Prev Med 2012; 42(6): 563-70.
[http://dx.doi.org/10.1016/j.amepre.2011.10.026] [PMID: 22608371]
[25]
Schmieder RE, Messerli FH, Garavaglia G, Nunez B. Glomerular hyperfiltration indicates early target organ damage in essential hypertension. JAMA 1990; 264(21): 2775-80.
[http://dx.doi.org/10.1001/jama.1990.03450210075036] [PMID: 2146412]
[26]
Choi HM, Hyun YY, Lee KB, Kim H. High estimated glomerular filtration rate is associated with coronary artery calcification in middle-aged Korean men without chronic kidney disease. Nephrol Dial Transplant 2015; 30(6): 996-1001.
[http://dx.doi.org/10.1093/ndt/gfv109] [PMID: 25994662]
[27]
Lin L, Peng K, Du R, et al. High glomerular filtration rate is associated with arterial stiffness in Chinese population. J Hypertens 2017; 35(2): 385-91.
[http://dx.doi.org/10.1097/HJH.0000000000001158] [PMID: 28005707]
[28]
Parvanova A, Abbate M, Yañez AM, et al. MAFLD and glomerular hyperfiltration in subjects with prediabetes, visceral obesity and “preserved” kidney function: A cross-sectional study. Diabetes Res Clin Pract 2023; 201: 110729.
[http://dx.doi.org/10.1016/j.diabres.2023.110729] [PMID: 37230296]
[29]
Valtuille R. Potential novel benefits of sodium restriction in chronic kidney disease. Curr Hypertens Rev 2021; 17(1): 59-66.
[http://dx.doi.org/10.2174/1573402116666200615152139] [PMID: 32538730]
[30]
Wuopio J, Lin Y-T, Orho-Melander M, Engström G, Ärnlöv J. The association between sodium intake and coronary and carotid atherosclerosis in the general Swedish population. Europ Heart J Open 2023; 3(2): oead024.
[http://dx.doi.org/10.1093/ehjopen/oead024] [PMID: 37006408]
[31]
Stevens PE, Levin A. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013; 158(11): 825-30.
[http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00007] [PMID: 23732715]
[32]
Eriksen BO, Løchen ML, Arntzen KA, et al. Subclinical cardiovascular disease is associated with a high glomerular filtration rate in the nondiabetic general population. Kidney Int 2014; 86(1): 146-53.
[http://dx.doi.org/10.1038/ki.2013.470] [PMID: 24304885]
[33]
Ould Setti M, Voutilainen A, Niskanen L, Tuomainen TP. The association between renal hyperfiltration and mortality is not mediated by diabetes mellitus. Int Urol Nephrol 2023; 55(10): 2639-45.
[http://dx.doi.org/10.1007/s11255-023-03562-9] [PMID: 36952107]
[34]
Van Biesen W, De Bacquer D, Verbeke F, Delanghe J, Lameire N, Vanholder R. The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J 2007; 28(4): 478-83.
[http://dx.doi.org/10.1093/eurheartj/ehl455] [PMID: 17223665]
[35]
Koo DJ, Lee MY, Jung I, et al. Increased risk of NAFLD in adults with glomerular hyperfiltration: An 8-Year cohort study based on 147,162 Koreans. J Pers Med 2022; 12(7): 1142.
[http://dx.doi.org/10.3390/jpm12071142] [PMID: 35887639]
[36]
Delanaye P, Melsom T, Ebert N, et al. Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: A review. Part 2: Why to measure glomerular filtration rate with iohexol? Clin Kidney J 2016; 9(5): 700-4.
[http://dx.doi.org/10.1093/ckj/sfw071] [PMID: 27679716]
[37]
Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367(1): 20-9.
[http://dx.doi.org/10.1056/NEJMoa1114248] [PMID: 22762315]
[38]
Delanaye P, Vidal-Petiot E, Björk J, et al. Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil and Africa. Nephrol Dial Transplant 2023; 38(1): 106-18.
[http://dx.doi.org/10.1093/ndt/gfac241] [PMID: 36002032]
[39]
Denic A, Mathew J, Lerman LO, et al. Single-nephron glomerular filtration rate in healthy adults. N Engl J Med 2017; 376(24): 2349-57.
[http://dx.doi.org/10.1056/NEJMoa1614329] [PMID: 28614683]
[40]
Pottel H, Hoste L, Dubourg L, et al. An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant 2016; 31(5): 798-806.
[http://dx.doi.org/10.1093/ndt/gfv454] [PMID: 26932693]
[41]
Kovesdy CPL, Furth S, Zoccali C. Obesity and kidney disease: Hidden consequences of the epidemic. Clin Kidney J 2017; 10(1): 1-8.
[http://dx.doi.org/10.1093/ckj/sfw139] [PMID: 28638599]
[42]
Maeda I, Hayashi T, Sato KK, et al. Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men. Clin J Am Soc Nephrol 2011; 6(10): 2462-9.
[http://dx.doi.org/10.2215/CJN.00700111] [PMID: 21885794]
[43]
Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33(1): 27-39.
[http://dx.doi.org/10.1093/ajcn/33.1.27] [PMID: 6986753]
[44]
Livingston EH, Lee S. Body surface area prediction in normal-weight and obese patients. Am J Physiol Endocrinol Metab 2001; 281(3): E586-91.
[http://dx.doi.org/10.1152/ajpendo.2001.281.3.E586] [PMID: 11500314]
[45]
So R, Song S, Lee JE, Yoon HJ. The association between renal hyperfiltration and the sources of habitual protein intake and dietary acid load in a general population with preserved renal function: The KoGES study. PLoS One 2016; 11(11): e0166495.
[http://dx.doi.org/10.1371/journal.pone.0166495] [PMID: 27846266]
[46]
Cho E, Choi SJ, Kang DH, Kalantar-Zadeh K, Ko GJ. Revisiting glomerular hyperfiltration and examining the concept of high dietary protein-related nephropathy in athletes and bodybuilders. Curr Opin Nephrol Hypertens 2022; 31(1): 18-25.
[http://dx.doi.org/10.1097/MNH.0000000000000755] [PMID: 34846311]
[47]
Tidmas V, Brazier J, Hawkins J, Forbes SC, Bottoms L, Farrington K. Nutritional and non-nutritional strategies in bodybuilding: Impact on kidney function. Int J Environ Res Public Health 2022; 19(7): 4288.
[http://dx.doi.org/10.3390/ijerph19074288] [PMID: 35409969]
[48]
Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 2002; 288(19): 2421-31.
[http://dx.doi.org/10.1001/jama.288.19.2421] [PMID: 12435255]
[49]
Titze J, Rakova N, Kopp C, Dahlmann A, Jantsch J, Luft FC. Balancing wobbles in the body sodium. Nephrol Dial Transplant 2016; 31(7): 1078-81.
[http://dx.doi.org/10.1093/ndt/gfv343] [PMID: 26410883]
[50]
Johnson RS, Titze J, Weller R. Cutaneous control of blood pressure. Curr Opin Nephrol Hypertens 2016; 25(1): 11-5.
[http://dx.doi.org/10.1097/MNH.0000000000000188] [PMID: 26625865]
[51]
Graudal N, Jürgens G, Baslund B, Alderman MH. Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: A meta-analysis. Am J Hypertens 2014; 27(9): 1129-37.
[http://dx.doi.org/10.1093/ajh/hpu028] [PMID: 24651634]
[52]
Hunter RW, Dhaun N, Bailey MA. The impact of excessive salt intake on human health. Nat Rev Nephrol 2022; 18(5): 321-35.
[http://dx.doi.org/10.1038/s41581-021-00533-0] [PMID: 35058650]
[53]
Afshin A, Sur PJ, Fay KA, et al. Health effects of dietary risks in 195 countries, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019; 393(10184): 1958-72.
[http://dx.doi.org/10.1016/S0140-6736(19)30041-8] [PMID: 30954305]
[54]
Zingerman B, Herman-Edelstein M, Erman A, et al. Effect of acetazolamide on obesity-induced glomerular hyperfiltration: A randomized controlled trial. PLoS One 2015; 10(9): e0137163.
[http://dx.doi.org/10.1371/journal.pone.0137163] [PMID: 26367377]
[55]
Vanholder R, Fouque D, Glorieux G, et al. Clinical management of the uraemic syndrome in chronic kidney disease. Lancet Diabetes Endocrinol 2016; 4(4): 360-73.
[http://dx.doi.org/10.1016/S2213-8587(16)00033-4] [PMID: 26948372]
[56]
Mark PB, Sarafidis P, Ekart R, et al. SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: A comprehensive review by EURECA-m and ERBP working groups of ERA. Nephrol Dial Transplant 2023; 38(11): 2444-55.
[http://dx.doi.org/10.1093/ndt/gfad112] [PMID: 37230946]
[57]
Wang M. Kidney benefits of SLGT2 inhibitors: Evidence from clinical trials. Nat Rev Nephrol 2023; 19(1): 3.
[http://dx.doi.org/10.1038/s41581-022-00659-9] [PMID: 36450917]
[58]
Fakhoury M, Levy R, Melamed ML. Vitamin D deficiency and kidney hyperfiltration: A mechanism of kidney injury? Ann Transl Med 2019; 7(S6): S207.
[http://dx.doi.org/10.21037/atm.2019.06.64] [PMID: 31656786]
[59]
Dey SK, Kumar S, Rani D, et al. Implications of vitamin D deficiency in systemic inflammation and cardiovascular health. Crit Rev Food Sci Nutr 2023; 1-18.
[http://dx.doi.org/10.1080/10408398.2023.2224880] [PMID: 37350746]
[60]
Yeung WG, Palmer SC, Strippoli GFM, et al. Vitamin D therapy in Adults With CKD: A systematic review and meta-analysis. Am J Kidney Dis 2023; 82(5): 543-8.
[http://dx.doi.org/10.1053/j.ajkd.2023.04.003]
[61]
Chang HC, Huang CJ, Yang AC, et al. Role of heart rate variability in association between glomerular hyperfiltration and all‐cause mortality. J Am Heart Assoc 2021; 10(24): e021585.
[http://dx.doi.org/10.1161/JAHA.121.021585] [PMID: 34889105]
[62]
Li J, Yu S, Tan Z, et al. High estimated glomerular filtration rate is associated with worse cognitive performance in the hypertensive population: Results from the china H-type hypertension registry study. Front Aging Neurosci 2022; 13: 706928.
[http://dx.doi.org/10.3389/fnagi.2021.706928] [PMID: 35250530]
[63]
Kwon SS, Lee H, Park BW, et al. Association of glomerular hyperfiltration with carotid artery plaque in the general population. Atherosclerosis 2023; 369: 30-6.
[http://dx.doi.org/10.1016/j.atherosclerosis.2023.01.016] [PMID: 36725419]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy